Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

Hospital Italiano de Buenos Aires360 enrolled

Overview

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year of use after their initiation during hospitalization in patients covered by our health insurance plan.

Study Type

OBSERVATIONAL

Enrollment

360

Conditions

Auricular Fibrillation Anticoagulant Drugs

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patient older than 18 years of age covered by our Health Care Insurance Plan. 2. Indication for oral anticoagulation with an expected duration of use of no less than 1 year. Exclusion Criteria: 1. Refusal to take part. 2. Use of oral anticoagulants within 6 months prior to admission. 3. Presence of mechanical prosthetic valve. 4. Chronic renal failure with creatinine clearance \<30 mL/min (estimated using the MDRD formula).

Locations (1)

Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

Outcomes

Primary Outcomes

Anticoagulant Discontinuation Rate

Time frame: One year

Secondary Outcomes

Discontinuation Predictors

Time frame: One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.